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Abstract
 
Transforming growth factor (TGF)-
 
b 
 
has been implicated in immunosuppression. However, it
remains obscure whether regulation of T cells by TGF-
 
b
 
 contributes to the immunosuppres-
sion in vivo. To address this issue, we developed transgenic mice expressing Smad7, an intra-
cellular antagonist of TGF-
 
b
 
/Smad signaling, selectively in mature T cells using a plasmid con-
struct coding a promoter element (the distal lck promoter) that directs high expression in
peripheral T cells. Peripheral T cells were not growth inhibited by TGF-
 
b
 
 in Smad7 transgenic
mice. Although Smad7 transgenic mice did not spontaneously show a specific phenotype, anti-
gen-induced airway inflammation and airway reactivity were enhanced in Smad7 transgenic
mice associated with high production of both T helper cell type 1 (Th1) and Th2 cytokines.
Thus, blockade of TGF-
 
b
 
/Smad signaling in mature T cells by expression of Smad7 enhanced
airway inflammation and airway reactivity, suggesting that regulation of T cells by TGF-
 
b
 
 was
crucial for negative regulation of the inflammatory (immune) response. Our findings also im-
plicated TGF-
 
b
 
/Smad signaling in mature T cells as a regulatory component of allergic asthma.
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Introduction
 
TGF-
 
b
 
 is a multifunctional cytokine that has diverse effects
 
on a variety of cell types (1). In the immune system, TGF-
 
b
 
regulates growth, differentiation, and function of macro-
 
phages, T cells, B cells, and NK cells (2–4). Importantly,
TGF-
 
b
 
 null mice developed extensive inflammation in
various organs and died shortly after birth, suggesting that
TGF-
 
b
 
 played a critical role in suppression of the immune
system in vivo (5, 6). Downregulation of T cell function by
inhibiting T cell proliferation is thought to be an important
means for TGF-
 
b
 
–mediated immunosuppression based on
in vitro studies. However, since TGF-
 
b
 
 acts on multiple
targets affecting the immune system (2), it remains obscure
whether negative regulation of T cells by TGF-
 
b
 
 contrib-
utes to the immunosuppression in vivo.
Recent identification of the Smad family of proteins has
advanced our understanding of how TGF-
 
b
 
 signals from
membrane to nucleus (7–10). The activated TGF-
 
b
 
 recep-
tors induce phosphorylation of Smad2 and Smad3, which
form heterooligomeric complexes with Smad4. The com-
plexes then translocate to the nucleus and regulate tran-
scriptional responses together with DNA binding cofactors.
Recently, Smad7 has been identified as an intracellular an-
tagonist of TGF-
 
b
 
 signaling; it inhibits TGF-
 
b
 
–induced
transcriptional responses (11–13). Smad7 associates with the
activated TGF-
 
b
 
 receptors and interferes with the activa-
tion of Smad2 and Smad3 by preventing their receptor in-
teraction and phosphorylation.
To determine whether negative regulation of T cells by
TGF-
 
b
 
 contributes to immunosuppression in vivo, we
 
have developed transgenic (Tg)
 
1
 
 mice expressing Smad7
preferentially in mature T cells using a plasmid construct
coding a promoter element (the distal lck promoter) that
directs high expression in peripheral T cells (14). This strat-
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egy also has the advantage of avoiding complications that
may occur by blocking TGF-
 
b
 
/Smad signaling in T cells
during early thymocyte maturation (15). Here, we showed
that antigen-induced airway inflammation and airway reac-
tivity were enhanced in Smad7 Tg mice, suggesting that
TGF-
 
b
 
/Smad signaling in mature T cells was crucial for
negative regulation of the inflammatory (immune) re-
sponse. Since antigen-induced airway inflammation and
airway reactivity in mice is a well-established model of al-
lergic asthma (16), our findings also implicated TGF-
 
b
 
/
Smad signaling in mature T cells as a regulatory component
of allergic asthma.
 
Materials and Methods
 
Generation of Tg Mice.
 
A 1.4-kb fragment including the full-
length mouse Flag-tagged Smad7 cDNA was removed from the
Smad7–pcDNA3 construct (13) by digestion with HindIII and
XhoI. This fragment was subcloned into a pGEM-4Z vector that
had been cut with HindIII-SalI. This pGEM-4Z vector contain-
ing Smad7 was cut with BamHI, and then ligated into the
BamHI site of the pUC19 vector containing the lck distal pro-
moter (14). In the pUC19 vector, the lck distal promoter se-
quences were fused at the BamHI site to the human growth
hormone (hGH) intronic and polyadenylation sequences, the
presence of which has been found to improve the expression of
cDNA transgenes in a nonspecific fashion. The diagrammatic
representation of the lck distal promoter–Smad7 transgene is
shown in Fig. 1 A. The SpeI fragment of these lck distal pro-
moter–Smad7 constructions was used for microinjection. The
transgenes were injected into the pronuclei of the fertilized eggs
of BDF1 mice. The Tg mice were identified by PCR and slot-
blot hybridization of genomic DNA to confirm the presence of
hGH sequences. C57BL/6 (B6) and BDF1 mice were purchased
from Clea, Inc. Transgene-positive founders were backcrossed to B6
mice to establish lines. Animal experiments were approved by the
Institutional Review Boards of Chiba and Juntendo Universities.
 
Purification of T Cells.
 
Mouse CD3
 
1
 
 T cells were purified
from spleens harvested from Smad7 Tg mice or wild-type (Wt)
littermates by Ficoll-Paque (Amersham Pharmacia Biotech) gra-
dient centrifugation of lymphocytes and magnetic cell sorting us-
ing MACS anti-CD3 microbeads (Miltenyi Biotec) following the
manufacturer’s recommendations. The purity of mouse CD3
 
1
 
 T
cells was confirmed by FACScan™ (Becton Dickinson) and was
consistently 
 
.
 
98%.
 
In Vitro Stimulation of T Lymphocytes.
 
For proliferation assays,
96-well microtiter plates were coated with 2 
 
m
 
g/ml of anti-
CD3
 
e
 
 mAb (2C11; BD PharMingen). Splenocytes (200 
 
m
 
l/well)
were added at a density of 10
 
6
 
 cells/ml and incubated in the pres-
ence or absence of TGF-
 
b
 
 (1 ng/ml) at 37
 
8
 
C in 5% CO
 
2
 
 for 72 h.
1 
 
m
 
Ci of [
 
3
 
H]thymidine (Amersham Pharmacia Biotech) was
added to the culture for the last 12 h. Thymidine incorporation
was assayed by harvesting cells with a PHD cell harvester (Cam-
bridge Technologies). For detection of phosphorylation of Smad2
in T cells, purified CD3
 
1
 
 T cells (10
 
6
 
 cells) from mouse spleen
were stimulated with TGF-
 
b
 
 (5 ng/ml) for 30 min followed by
immunoblotting. For cytokine assays, spleen cells (5 
 
3
 
 10
 
6
 
 cells)
isolated from mice sensitized with OVA at 2-wk intervals were
restimulated with OVA (100 
 
m
 
g/ml) 7 d after the second sensiti-
zation. 72 h after the culture, supernatants were collected for
measurement of cytokines.
 
Western Blots.
 
Immunoblotting with anti-Flag antibody (Sigma-
Aldrich), anti-Smad2 antibody (Transduction Laboratories), an-
tiphosphorylated Smad2 antibody (17), or anti-Smad7 antibody
(KAF) (17) was performed as described previously (18).
 
Flow Cytometry.
 
FACS
 
®
 
 analysis was performed as described
previously (19). In brief, thymus or spleen cells (10
 
6
 
) suspended
in PBS containing 0.1% NaN
 
3
 
 and 1% FCS were incubated on
ice with a mixture of FITC-labeled anti-CD4, PE-labeled anti-
CD8, PE-labeled anti-B220, and PE-labeled anti-CD25 antibod-
ies (BD PharMingen). For intracellular cytokine staining, bron-
choalveolar lavage (BAL) cells were stained with a mixture of
Cy-Chrome–labeled anti-CD4, fixed and permeabilized using a
Cytofix/Cytoperm kit (BD PharMingen), and then stained using
FITC-labeled anti–IFN-
 
g
 
 antibody and PE-labeled anti–IL-4 an-
tibody (BD PharMingen) according to the manufacturer’s recom-
mendations. After gating on CD4 T cells, results were analyzed
on a FACSCalibur™ (Becton Dickinson) using CellQUEST™
software (Becton Dickinson).
 
Immunization and Exposure of Mice.
 
5–8-wk-old Tg mice or
Wt littermates were immunized intraperitoneally with 1 
 
m
 
g of
chicken OVA (Sigma-Aldrich) in 4 mg of aluminum hydroxide
at 2-wk intervals. 10 d after the second immunization, the sensi-
tized mice inhaled aerosolized OVA (50 mg/ml) dissolved in
0.9% saline by a DeVilbiss 646 nebulizer for 30 min for three
consecutive days as described previously (20). As a control, 0.9%
saline alone was administered by the nebulizer.
 
BAL.
 
BAL was performed as described previously (21). In
brief, 48 h after OVA inhalation, the mice were killed by cervical
dislocation, the trachea was cannulated, and the airway lumen
was washed three times with 0.3 ml of PBS. The BAL fluid
(BALF) was centrifuged at 400 
 
g 
 
for 10 min at 4
 
8
 
C, and the
amount of IL-5, IFN-
 
g
 
, and TGF-
 
b
 
 in the supernatant was mea-
sured by enzyme immunoassay as described below. The BAL
cells were resuspended in 0.2 ml of PBS and counted using a
hemocytometer. For differential cell counts, 2–4 
 
3
 
 10
 
3
 
 cells were
spun onto glass slides (Cytospin), air dried, fixed with ethanol,
and stained with Giemsa solution. The number of eosinophils,
neutrophils, lymphocytes, and macrophages in 200 cells was
counted based on morphology.
 
Antigen-induced Eosinophil Infiltration in Mouse Trachea.
 
Anti-
gen-induced eosinophil infiltration in mouse trachea was evalu-
ated as described previously (20). In brief, at 48 h after the inhala-
tion, the trachea was excised, fixed in 10% formalin, and stained
with Luna solution. The number of eosinophils in the submu-
cosal tissue of trachea was counted in Luna-stained sections and
expressed as the number of eosinophils per the length of the base-
ment membrane of trachea, which was measured with a digital
curvimeter.
 
Cytokine ELISA.
 
The amount of IL-4, IL-5, and IFN-
 
g
 
 in
the culture supernatant of spleen cells or BALF was determined
using murine IL-4 and IL-5 ELISA kits (Endogen) and an IFN-
 
g
 
ELISA kit (Nalgen). The amount of TGF-
 
b
 
 in the supernatant of
BALF or plasma was measured using a human TGF-
 
b
 
1 ELISA
kit (R&D Systems) that detects mouse TGF-
 
b
 
1 protein because
of the high homology of TGF-
 
b
 
1 across species. The assay de-
tects only the active form of TGF-
 
b
 
1. Samples were activated
before measuring according to the manufacturer’s recommenda-
tions. The minimum significant value of IL-4, IL-5, IFN-
 
g
 
, and
TGF-
 
b
 
1 was 5, 5, 1, and 5 pg/ml, respectively.
 
Measurement of Airway Responsiveness.
 
Airway responsiveness
to acetylcholine challenge was measured as described (21). In
brief, at 24 h after OVA or saline inhalation, mice were anesthe-
tized with pentobarbital (50 mg/kg; Abbott Laboratories), intu- 
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bated with a 20-gauge tracheal cannula, and ventilated at a rate of
120 breaths/min with a constant tidal volume of air (0.2 ml). Air-
way pressure was measured with a pressure transducer via a port
of the tracheal cannula. Muscle paralysis was provided by intrave-
nous administration of pancuronium bromide (0.1 mg/kg; Tocris
Cookson). After establishment of a stable airway pressure record-
ing, acetylcholine (500 mg/kg; Wako) was injected intravenously,
and the changes in airway pressure were recorded. Airway re-
sponsiveness was defined by the time-integrated change in peak
airway pressure (airway pressure–time index [APTI]; cmH
 
2
 
O 
 
?
 
 s).
 
Data Analysis.
 
Data are summarized as mean 
 
6 
 
SD. The sta-
tistical analysis of the results was performed by analysis of variance
using Fisher’s least significant difference test for multiple compar-
isons.
 
 P 
 
, 
 
0.05 was considered significant.
 
Results
 
Generation of Smad7 Tg Mice.
 
To express the Smad7
transgene preferentially in peripheral T cells, we used a
plasmid construct expressing Flag-tagged mouse Smad7
(13) under the control of a promoter element (the distal lck
promoter) that directed high expression in mature thy-
mocytes and peripheral T cells (14; Fig. 1 A). The strategy
also has the advantage of avoiding complications that may
occur by blocking TGF-
 
b
 
/Smad signaling in T cells during
early thymocyte maturation (15). We obtained five trans-
genic lines, out of which two lines displayed relatively high
levels of transgene expression in the spleen (Fig. 1 B).
Some level of expression was detected in the thymus (Fig.
1 B), and little expression was observed in the lungs or
other organs that were not enriched in T cells (data not
shown). We also confirmed expression of the Smad7 trans-
 
gene in peripheral blood lymphocytes and CD3
 
1
 
 T cells
purified from the spleens of Smad7 Tg mice (data not
shown). In addition, endogenous Smad7 protein was not
detected in CD3
 
1
 
 T cells purified from the spleens of Wt
mice and Smad7 Tg mice by Western blotting with anti-
Smad7 antibody (data not shown).
 
Lack of Responsiveness to TGF-
 
b
 
 in Splenic T Cells from
Smad7 Tg Mice.
 
To determine whether peripheral T cells
expressing the Smad7 transgene were resistant to TGF-
 
b
 
action, we examined the proliferation of splenocytes iso-
lated from Smad7 Tg mice and Wt littermates when acti-
vated with mAb to CD3 in the presence and absence of
TGF-
 
b
 
. Without stimulation of mAb to CD3, splenocytes
from Smad7 Tg mice and Wt littermates did not proliferate
(data not shown). The growth-inhibitory effect of TGF-
 
b
 
was largely lost in splenocytes from Smad7 Tg mice when
activated with mAb to CD3, although similarly treated Wt
splenocytes were growth inhibited 
 
z
 
60% by TGF-
 
b
 
 (Fig.
2 A). The purified population of CD3
 
1
 
 T cells isolated
from the spleens of Smad7 Tg mice and activated by anti-
CD3 was also insensitive to the inhibitory effect of TGF-
 
b
 
(data not shown). Interestingly, the non–TGF-
 
b
 
–treated
levels of proliferation were about threefold higher in sple-
nocytes from Smad7 Tg mice than in those from Wt litter-
mates (Fig. 2 A).
Figure 1. Generation of Smad7 Tg mice. (A) Schematic diagram of
constructs used for peripheral T cell–specific expression of the mouse
Flag-tagged Smad7 transgene. (B) Expression of the Flag-tagged Smad7
transgene in Smad7 Tg mice. Whole cell lysates were prepared from thy-
mus (thy.) or spleen (sp.) from Smad7 Tg mice or Wt littermates, and
subjected to Western blot (WB) analysis using anti-Flag antibody to de-
tect protein expression of the Flag-tagged Smad7 transgene. As a positive
control, cell lysate from COS7 cells transfected with Flag-tagged Smad7
(F-Smad7) cDNA was used.
Figure 2. Altered responsiveness of splenic T cells from Smad7 Tg
mice to TGF-b. (A) Lack of responsiveness to TGF-b in splenocytes
from Smad7 Tg mice. Splenocytes from Smad7 Tg mice or Wt litter-
mates were stimulated with anti-CD3 mAb in the presence or absence
(control) of TGF-b (1 ng/ml). Aliquots of cells were pulsed with
[3H]thymidine, and incorporated counts (in cpm) were determined.
Shown are means 6 SD of [3H]thymidine corporation from triplicate cul-
tures. The results are from one representative experiment out of three.
(B) Inhibition of TGF-b–mediated phosphorylation of Smad2 in purified
T cells from Smad7 Tg mice. Cell lysates were prepared from purified
CD31 T cells from Smad7 Tg mice or Wt littermates, and then immuno-
blotted with antiphosphorylated Smad2 antibody (top, P-Smad2) or anti-
Smad2 antibody (bottom). The results are from one representative exper-
iment out of three.154 Experimental Asthma in Smad7 Transgenic Mice
Phosphorylation of Smad2 and Smad3 by activated
TGF-b receptors is a key event for the initiation of TGF-b
signal transduction (18, 22), and Smad7 antagonizes TGF-b
signaling by preventing TGF-b receptor–mediated phos-
phorylation of Smad2 and Smad3 (13). Thus, we next de-
termined whether phosphorylation of Smad2 by TGF-b
was inhibited in peripheral T cells from Smad7 Tg mice. As
shown in Fig. 2 B, we found that TGF-b–mediated phos-
phorylation of Smad2 was suppressed in CD31 T cells pu-
rified from the spleens of Smad7 Tg mice in contrast to
those from Wt littermates (Fig. 2 B). These findings indi-
cated that peripheral T cells from Smad7 Tg mice were in-
sensitive to TGF-b.
Normal T Cell and B Cell Development in Smad7 Tg
Mice. To determine whether any developmental defect in
the immune system was observed in Smad7 Tg mice, we
examined thymic and splenic T and B cell populations by
performing FACS® analysis. As shown in Fig. 3 A, the
thymi of Smad7 Tg mice contained normal proportions of
CD4 and CD8 single- and double-positive T cells, suggest-
ing that thymic T cell maturation is normal in Smad7 Tg
mice. Similarly, the spleens from Smad7 Tg mice contained
normal numbers and percentages of B cells and CD4 and
CD8 single-positive cells, suggesting that there was not an
abnormal expansion of lymphocytes in the spleens of
Smad7 Tg mice (Fig. 3 B). These findings indicated that
Smad7 Tg mice did not have any developmental defect in
their immune system.
Normal Phenotype of Smad7 Tg Mice. The Smad7 Tg
mice we developed were viable, survived to adulthood,
and were phenotypically indistinguishable from their litter-
mate controls at birth and at least until 6 mo of age. Histo-
logical examination of lungs or other organs did not show
any morphological abnormalities or inflammatory lesions in
Smad7 Tg mice (data not shown).
Enhanced Antigen-induced Airway Inflammation in Smad7 Tg
Mice. Since Smad7 Tg mice showed a normal phenotype,
contrary to our expectations, we asked whether Smad7 Tg
mice were any different in pathological situations, particu-
larly in inflammation. Thus, to determine whether TGF-b/
Smad signaling in T cells contributes to regulation of the
inflammatory response, we developed airway inflammation
in Smad7 Tg mice by inhalation of antigen (OVA) after an-
tigen sensitization as described previously (20). 48 h after
the inhaled OVA challenge, BALF was recovered from the
animal, and the total cell number in the BALF was counted
by cell differentiation analysis. As shown in Fig. 4 A, the to-
tal cell count in the BALF recovered from Smad7 Tg mice
upon OVA challenge was threefold higher than that in the
BALF derived from Wt littermates. Cell differentiation
analysis revealed that the number of eosinophils, neutro-
phils, and lymphocytes in the BALF was significantly in-
creased in Smad7 Tg mice compared with Wt littermates,
indicating that OVA-induced airway inflammation was en-
hanced in Smad7 Tg mice in general (Fig. 4 A). In addi-
tion, eosinophil infiltration into the mouse trachea after
OVA inhalation was also two- to fourfold higher in Smad7
Tg mice than in Wt littermates (Fig. 4 B). These findings
indicated that antigen-induced airway inflammation was
enhanced in Smad7 Tg mice, suggesting that TGF-b/Smad
signaling in mature T cells had a negative regulatory role in
the development of antigen-induced airway inflammation.
Cytokine Production in Smad7 Tg Mice. Since antigen-
induced airway inflammation was enhanced in Smad7 Tg
mice, we focused on the mechanisms underlying these ob-
servations. Because we have previously shown that IL-5
and IFN-g regulate antigen-induced airway inflammation
positively and negatively, respectively (20, 23), we exam-
ined antigen-induced IL-5 and IFN-g production in the
airways of sensitized mice. IL-5 and IFN-g levels in the
BALF of Smad7 Tg mice were significantly higher at 48 h
after OVA inhalation than those of Wt littermates (Fig. 5
A). Little IL-5 or IFN-g was detected in the BALF of
Smad7 Tg mice or Wt littermates after saline inhalation
(data not shown). In addition, in vitro OVA-induced IL-4,
IL-5, and IFN-g production was significantly higher in the
spleen cells of Smad7 Tg mice than those of Wt littermates
(Fig. 5 B). TGF-b levels in the BALF of Smad7 Tg mice at
48 h after OVA inhalation were equivalent to those of Wt
littermates (Fig. 5 C). In addition, there was no significant
difference in plasma TGF-b levels between Smad7 Tg
mice and Wt littermates (Smad7 Tg mice: 1.4 6 0.4 ng/
ml; Wt littermates: 1.2 6 0.5 ng/ml; n 5 5, P 5 0.49).
These findings indicated that antigen-induced production
Figure 3. Normal T cell and B cell development in Smad7 Tg mice.
FACS® analysis of thymocytes (A) or splenocytes (B) using the indicated
conjugated antibodies. All data were gated for viable cells. Percentages
represent proportions of viable cells in each region or quadrant. The re-
sults are from one representative experiment out of three.155 Nakao et al.
of Th1 and Th2 cytokines was higher in Smad7 Tg mice
than in Wt littermates.
Activated Phenotype of T Lymphocytes in the Airways of
Smad7 Tg Mice. Since we found enhanced IL-5 and IFN-g
levels in the BALF of Smad7 Tg mice upon OVA chal-
lenge (Fig. 5 A), we further assessed T cell phenotype in
the BALF of Smad7 Tg mice. As shown in Fig. 6, the
number of CD4 T cells, CD8 T cells, and CD251 CD4 T
cells (activated phenotype) in the BALF of Smad7 Tg mice
was higher than that of Wt littermates upon OVA chal-
lenge. Little T cell infiltration into the BALF of Smad7 Tg
mice and Wt littermates was observed upon saline chal-
lenge (data not shown). In addition, IL-4 and IFN-g pro-
duction in CD4 T cells in the BALF was enhanced in
Smad7 Tg mice (Fig. 6 C). These findings indicated that T
cell infiltration into the airways of Smad7 Tg mice was en-
hanced and that the infiltrating T cells were more activated
in Smad7 Tg mice than in Wt littermates.
Airway Hyperresponsiveness in Smad7 Tg Mice. Airway
hyperresponsiveness (AHR) is associated with airway in-
flammation and Th2 cytokines, and is a central feature of
asthma (16). Thus, we examined antigen-induced AHR in
Smad7 Tg mice. Inhaled OVA challenge of sensitized Wt
mice resulted in a significant increase in airway responsive-
ness to acetylcholine (APTI: control 1,812 6 64 vs. OVA
2,246 6 98; n 5 5, P , 0.005; Fig. 7) as described previ-
ously (21). OVA-induced AHR in sensitized Smad7 Tg
mice was significantly higher than that in Wt littermates
(APTI: Wt 2,246 6 98 vs. Tg 2,742 6 109; n 5 5, P ,
0.005; Fig. 7). These results indicated that overexpression
of Smad7 in mature T cells enhanced antigen-induced
AHR, suggesting that TGF-b/Smad signaling in mature T
cells played a negative role in antigen-induced AHR in
sensitized mice.
Discussion
In this study, we developed Tg mice expressing Smad7
under the control of a distal lck promoter (14), so that we
were able to block the TGF-b/Smad signaling pathway
preferentially in peripheral T cells. The Tg mice enabled us
to determine whether TGF-b/Smad signaling in mature T
cells contributed to regulation of the immune system in
vivo. We found that Smad7 Tg mice did not spontaneously
show a specific phenotype, but showed enhanced antigen-
induced airway inflammation and airway reactivity (Figs. 4
and 7). The findings suggested that TGF-b/Smad signaling
in mature T cells contributed to negative regulation of the
inflammatory (immune) response, but not to T cell ho-
meostasis under normal circumstances.
Figure 4. Antigen-induced airway inflammation in Smad7 Tg mice.
OVA-sensitized mice were challenged with inhalation of OVA as de-
scribed in Materials and Methods. Leukocyte infiltration in the BALF (A)
and eosinophil infiltration into the trachea (B) of the sensitized mice were
then examined at 48 h after OVA inhalation. Data are means 6 SD for
five mice in each group. The results are from one representative experi-
ment out of three. Eos, eosinophils; Neut, neutrophils; Lymph, lympho-
cytes; Mac, macrophages. *P , 0.05, significantly different from the mean
value of the corresponding control response (Wt).
Figure 5. Cytokine production in Smad7 Tg mice. OVA-sensitized
mice were challenged with inhalation of OVA. At 48 h after the inhala-
tion, BALF was collected as described in Materials and Methods. For de-
tection of cytokines in the culture supernatant, spleen cells were isolated
from the mice sensitized with OVA/alum and stimulated with OVA (100
mg/ml) in vitro. 72 h after the stimulation, the culture supernatants were
collected. IL-5 and IFN-g levels in the BALF (A), OVA-induced IL-4,
IL-5, and IFN-g production in the supernatant of spleen cells from the
sensitized mice (B), and TGF-b1 levels in the BALF (C) were determined
by ELISA. Data are means 6 SD for five mice in each group. The results
are from one representative experiment out of three. *P , 0.05, signifi-
cantly different from the mean value of the corresponding control re-
sponse (Wt).156 Experimental Asthma in Smad7 Transgenic Mice
Antigen-induced airway inflammation and airway reac-
tivity in mice is a well-established model of allergic asthma
(16). Thus, the finding that overexpression of Smad7 in
mature T cells enhanced antigen-induced airway inflam-
mation and airway reactivity (Figs. 4 and 7) also implicated
TGF-b/Smad signaling as a regulatory component of aller-
gic asthma. The role of TGF-b/Smad signaling in the
pathophysiology of asthma remains unclear. Since our re-
sults suggested the importance of TGF-b/Smad signaling
in the suppression of allergic airway inflammation, the
pathological role of TGF-b/Smad signaling in asthmatic
airways should be investigated in the future.
Contrary to our prediction based on the previous finding
that TGF-b null mice developed severe inflammation in
various organs and an autoimmune phenotype (5, 6),
Smad7 Tg mice did not spontaneously show a specific phe-
notype. We also found that development of T cells and B
cells was normal in Smad7 Tg mice (Fig. 3). These findings
suggested that TGF-b/Smad signaling in mature T cells
was not critical for T cell homeostasis under normal cir-
cumstances.
The spontaneous phenotype presented here was also dis-
tinct from those recently reported by three groups in
Smad3 null mice in which splenic T cells were insensitive
to TGF-b (19, 24, 25). Intestinal malignancy (24), a pro-
gressive illness associated with opportunistic infection (19),
and an early phenotype of forelimb malformation (25) were
not observed in our Smad7 Tg mice. In addition, impaired
local inflammation in the process of wound healing was re-
cently reported in Smad3 null mice (26). Since TGF-b acts
on multiple targets including epithelial cells, neutrophils,
and macrophages/monocytes (1), Smad3 null mice should
have defects in a variety of TGF-b–responsive cells. For in-
stance, the reduced inflammation during the process of
wound healing could be attributed to a blunted chemotac-
tic response of monocytes and neutrophils to TGF-b (26).
In our Smad7 Tg mice, those cells are intact in the TGF-b
response. Thus, the T cell–selective inhibition of TGF-b/
Smad signaling could explain at least in part the phenotypic
differences observed between Smad7 Tg mice and Smad3
null mice.
Antigen-induced airway inflammation was enhanced in
Smad7 Tg mice (Fig. 4). Since CD4 T cells and IL-5 play a
central role in regulating antigen-induced airway inflam-
mation (20) and antigen-induced IL-5 production was
enhanced in Smad7 Tg mice (Fig. 5), the enhanced antigen-
induced airway inflammation could be attributed to the
enhanced IL-5 production in Smad7 Tg mice. CD4 T cells
were thought to be a major source of IL-5 production in
the airways because we had preliminary data that IL-5 (and
also INF-g) production in the BALF of sensitized mice af-
ter OVA challenge was not detected after depletion of
CD4 T cells with anti-CD4 antibody immediately before
the OVA challenge (data not shown).
Recently, a cooperative role of Th1 cells with Th2 was
reported (27, 28), indicating that IFN-g at physiologically
relevant levels was insufficient to neutralize the effects of
IL-5 in vivo. Thus, although we observed enhanced IFN-g
production in Smad7 Tg mice (Fig. 5), relative contribu-
tions of IFN-g to the airway inflammation might be small.
We found that T cells infiltrating into the airways were
increased and more activated in Smad7 Tg mice (Fig. 6). In
addition, production of TGF-b, which was shown to in-
hibit the production of and response to cytokines in T cells
(4), in the airways of Smad7 Tg mice was equivalent in Wt
littermates (Fig. 5 C). Taken together, these findings sug-
gested that enhanced IL-5 and IFN-g production in the
airways of Smad7 Tg mice might be due to the enhanced
activation of T cells that could have escaped from the in-
hibitory action of TGF-b.
Figure 6. Activated phenotype in T lymphocytes in the airways of
Smad7 Tg mice. Representative FACS® profiles of CD4 versus CD8
staining (A), CD4 versus CD25 staining (B), and intracellular staining of
IL-4 versus IFN-g in CD4 T cells (C), on BALF cells using anti-CD4–
FITC, anti-CD8–PE, anti-CD25–PE, anti–IFN-g–FITC, and anti–IL-4–
PE antibodies (n 5 5 mice in each group). Percentages represent propor-
tions of viable cells in each region or quadrant.
Figure 7. Airway responsive-
ness to acetylcholine of Smad7 Tg
mice. OVA-sensitized mice were
challenged with inhalation of
OVA (black bars) or saline (white
bars). At 24 h after the inhalation,
airway responsiveness was assessed
by the time-integrated change in
peak airway pressure (APTI;
cmH2O ? s) after intravenous ace-
tylcholine challenge. Data are means 6 SD for five mice in each group.
The results are from one representative experiment out of three. *P , 0.05,
significantly different from the mean value of the corresponding control re-
sponse (Wt).157 Nakao et al.
Another reason for the enhanced cytokine production in
Smad7 Tg mice might be that blockade of TGF-b/Smad
signaling by Smad7 in T cells augmented differentiation of
naive T cells into both Th1 and Th2 cells, resulting in en-
hanced cytokine production. The role of TGF-b/Smad
signaling in T cell differentiation towards Th1 and/or Th2
subsets is still unclear (4). Our findings of higher produc-
tion of IL-4, IL-5, and IFN-g in Smad7 Tg mice than in
Wt littermates (Figs. 5 and 6) suggested that generation of
Th1 and Th2 cells was enhanced under the conditions in
which differentiation of T cells was not influenced by
TGF-b. However, more defined experiments using a puri-
fied population of CD41 T cells are clearly needed to claim
that generation of Th1 and Th2 cells was enhanced in
Smad7 Tg mice.
Furthermore, most recently Gorelik et al. showed that
abrogation of TGF-b signaling in T cells led to a spontane-
ous autoimmune phenotype using Tg mice expressing the
dominant-negative TGF-b type II receptor selectively in T
cells (29). Their Tg mice developed inflammatory infiltra-
tion in several organs and circulating autoimmune antibod-
ies after 3–4 mo of age, which were not seen in our Smad7
Tg mice. The different mouse backgrounds may explain
this difference, since their Tg mice were backcrossed onto
a B10.BR background whereas our Tg mice were back-
crossed onto a B6 background. Another explanation is that
there may be TGF-b signals that are not blocked by over-
expression of Smad7 in T cells, which would lead to the
largely normal phenotype in our Smad7 Tg mice. The lat-
ter possibility should be investigated in the future.
In summary, we showed that blockade of TGF-b/Smad
signaling in mature T cells by overexpression of Smad7 en-
hanced antigen-induced airway inflammation and airway
reactivity. Our findings suggested that TGF-b/Smad sig-
naling in mature T cells was crucial for negative regulation
of the inflammatory (immune) response. Our findings also
implicated TGF-b/Smad signaling in mature T cells as a
regulatory component of allergic asthma.
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